PDZ‐binding kinase inhibitor OTS514 suppresses the proliferation of oral squamous carcinoma cells

E2F E2F1
DOI: 10.1111/odi.14533 Publication Date: 2023-02-17T10:58:44Z
ABSTRACT
PDZ-binding kinase (PBK) has been reported as a poor prognostic factor and is promising molecular target for anticancer therapeutics. Here, we aimed to investigate the effect of specific PBK inhibitor OTS514 on survival OSCC cells.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (44)
CITATIONS (0)